Adequate Vitamin D Status is Associated with the Reduced Odds of Prevalent Diabetic Retinopathy in African Americans and Caucasians
Overview
Endocrinology
Authors
Affiliations
Background: Vitamin D status has been hypothesized to protect against development of diabetic retinopathy via its anti-inflammatory and anti-angiogenic properties. Additionally, in vitro and in vivo studies suggest vitamin D favorably influences blood pressure and blood glucose control, strong risk factors for diabetic retinopathy. We examined the association between vitamin D status and prevalent diabetic retinopathy in participants with diabetes from a population-based cohort.
Methods: Among participants in the Atherosclerosis Risk in Communities (ARIC) study with diabetes at visit 3 (1993-1995), 1339 (906 Caucasians, 433 African Americans) had serum 25-hydroxyvitamin (25[OH]D) concentrations assessed at visit 2 (1989-1992) and nonmydriatic retinal photographs taken at visit 3. Dietary intake of vitamin D was assessed at visit 1 (1987-1989). Logistic regression was used to estimate odds ratios (ORs) and 95 % confidence intervals (CIs) for diabetic retinopathy by categories of season-adjusted 25(OH)D (<30 [referent], 30-<50, 50-<75 and ≥75 nmol/L), by quartile of vitamin D intake (IU/day), and use of vitamin D or fish oil supplements (yes/no). P for trend was estimated using continuous 25(OH)D or vitamin D intake. ORs were adjusted for race, and duration of diabetes. We further adjusted for HBA1c and hypertension to examine if 25(OH)D influenced diabetic retinopathy via its effects on either glycemic control or blood pressure.
Results: ORs (95 % CIs) for retinopathy, adjusted for race and duration, were 0.77 (0.45-1.32), 0.64 (0.37-1.10), and 0.39 (0.20-0.75), p for trend = 0.001, for participants with 25(OH)D of 30-<50, 50-<75, and ≥75 nmol/L, respectively. Further adjustment for hypertension minimally influenced results (data not show), but adjustment for HBA1c attenuated the OR among those with 25(OH)D ≥75 (0.47 [0.23-0.96], p for trend = 0.030). No statistically significant association was observed between vitamin D intake from foods or supplements and retinopathy.
Conclusions: 25(OH)D concentrations ≥75 nmol/L were associated with lower odds of any retinopathy assessed 3 years later. We speculate this may be due in part to vitamin D's influence on blood glucose control.
DAngelo A, Lixi F, Vitiello L, Gagliardi V, Pellegrino A, Giannaccare G Biomed Res Int. 2025; 2025:6654976.
PMID: 40041571 PMC: 11876532. DOI: 10.1155/bmri/6654976.
Petrea C, Ghenciu L, Iacob R, Stoicescu E, Sandesc D Biomedicines. 2025; 13(1).
PMID: 39857652 PMC: 11762121. DOI: 10.3390/biomedicines13010068.
Development and external validation of a predictive model for type 2 diabetic retinopathy.
Li Y, Hu B, Lu L, Li Y, Caika S, Song Z Sci Rep. 2024; 14(1):16741.
PMID: 39033211 PMC: 11271465. DOI: 10.1038/s41598-024-67533-5.
The Role of Natural Products in Diabetic Retinopathy.
Zhao Y, Chen Y, Yan N Biomedicines. 2024; 12(6).
PMID: 38927345 PMC: 11200400. DOI: 10.3390/biomedicines12061138.
A Mediterranean Diet May Be Protective in the Development of Diabetic Retinopathy.
Bryl A, Mrugacz M, Falkowski M, Zorena K Int J Mol Sci. 2023; 24(13).
PMID: 37446322 PMC: 10342183. DOI: 10.3390/ijms241311145.